Almac Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - The analyst’s summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Almac Group Ltd (Almac) is a contract development and manufacturing organization. The company provides integrated services to pharmaceutical and biotechnology companies. The company offers a comprehensive range of services across the lifecycle of biopharmaceutical products which extend from research through pharmaceutical and clinical development to the commercialization of products. Its services portfolio encompasses diagnostics and biomarker development, clinical technologies, Active Pharmaceutical Ingredient (API) services and chemical development, pharmaceutical development, analytical services, clinical services and commercial services. The company operates through its subsidiaries in California, North Carolina, and Pennsylvania in the US and Singapore. Almac is headquartered in Craigavon, Northern Ireland, the UK.Almac Group Ltd Key Recent Developments
- Mar 06, 2024: Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity
- Feb 06, 2024: Almac Group Signs Virtual Power Purchase Agreement (Vppa) for Renewable Energy Reducing Their Global Scope 2 Emissions by 46%
- Jan 25, 2024: Almac Sciences Extends selectAZyme Offering to Include Therapeutic Oligonucleotide Synthesis
- Aug 07, 2023: Almac Group Marks Groundbreaking of $65 Million Facility Expansion in Montgomery County
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company’s Lifesciences Financial Deals and Alliances
Section 4 - Company’s Recent Developments
Section 5 - Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aurelia Bioscience Ltd
- Alcami Corp
- IQVIA Holdings Inc
- Cobra Biologics Ltd
- Codexis Inc
- Incyte Corp
- Alexion Pharmaceuticals Inc